News

The Alzheimer’s Association – New York City Chapter will collaborate with the Delta Rho Omega chapter of Alpha Kappa Alpha Sorority in February to raise awareness about Alzheimer’s disease during Black History Month. The collaboration aims to highlight the prevalence of Alzheimer’s in the African-American community, and involves campus officials…

Removing a protein involved in neuroinflammation is beneficial in early stages of Alzheimer’s disease in mice. However, in late disease stages of the disease, this action has the opposite effect, according to an animal study that helps explain contradicting results observed in earlier research. The findings highlight the role of neuroinflammation…

Epileptic activity appear to be more frequent in patients with Alzheimer’s disease than in healthy individuals and may be linked to disease progression, according to a recent study. These findings, previously seen in animals, suggest that increased neuronal excitability, a feature of epilepsy, may also contribute to the onset and progression of…

The non-profit UsAgainstAlzheimers organization has started a program that has a key goal of addressing African-American and Latino underrepresentation in neurological research. Recognizing that Alzheimers disproportionately affects people of color, another goal of the program will be to build a national network of doctors, researchers, patients, caregivers and others involved…

Trials of deep brain stimulation for Alzheimer’s disease bring with them unique ethical challenges that need to be addressed because these studies are progressing, researchers argue in a recent review article. The trio behind the review — researchers from the University of Pennsylvania — not only raised points for concern, but also provided potential…

Low glucose levels in the brain are known to lead memory problems and cognitive decline, and new research suggests they do so by triggering a series of molecular reactions that ultimately kill neurons. These findings provide fresh insight into changes that set the stage for Alzheimer’s disease. The research also identified a protein that appears…

Dan Gasby, a television producer, author, and Alzheimer’s disease advocate, is teaming up with the nonprofit American Brain Foundation (ABF) to support and advance research into brain and nervous system disorders, especially for African-Americans. He’ll undoubtedly be a strong voice on the ABF’s board of directors, to which he was recently appointed.

Researchers believe that processes that can be used to control immune reactions toward a virus may also be used to prevent neurodegeneration in conditions such as Alzheimer’s disease. To achieve this, researchers blocked the protein PLSCR1 in the brain — a move that prevented immune cells called microglia from attacking…